EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis

Anna Pafiti, George Krashias, John Tzartos, Socrates Tzartos, Christos Stergiou, Eftychia Gaglia, Irene Smoleski, Christina Christodoulou, Marios Pantzaris iD, Anastasia Lambrianides

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241310787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna Pafiti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate School, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Cyprus Institute of Neurology and Genetics, Greek EPANEK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurofilament light chain (NfL), is a neuron-specific cytoskeletal protein detected in extracellular fluid following axonal damage. Extensive research has focused on NfL quantification in CSF, establishing it as a prognostic biomarker of disability progression in Multiple Sclerosis (MS). Our study used a new commercially available Enzyme-Linked Immunosorbent Assay (ELISA) kit and Single Molecular Array (Simoa) advanced technology to assess serum NfL levels in MS patients and Healthy Controls (HC). Verifying the most accurate, cost-effective methodology will benefit its application in clinical settings. Blood samples were collected from 54 MS patients and 30 HC. Protocols accompanying the kits were followed. The ELISA thershold was set as 3 S.D. above the mean of the HC. For Simoa, the Z-score calculation created by Jens Kuhle’s group was applied (with permission). Samples exceeding the threshold or z-score ≥1.5 indicated subclinical disease activity. To our knowledge, this is the first study to find strong-positive correlation between ELISA and Simoa for the quantification of NfL in serum (r = 0.919). Despite the strong correlation, Simoa has better analytical sensitivity and can detect small changes in samples making it valuable in clinical settings. Further research is required to evaluate whether serum NfL quantification using ELISA could be utilized to predict disability progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansIntermediate FilamentsEnzyme-Linked Immunosorbent AssayAxonsNeurofilament ProteinsBiomarkers

Stichwörter der Autor:innen

enzyme-linked immunosorbent assaymultiple sclerosisneurofilament light chainsingle molecular array advanced technology

Substanzen

Neurofilament ProteinsBiomarkers

Autor:innen und Institutionen

  • Postgraduate School, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
  • Neuroimmunology Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
  • Department of Molecular Virology, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
  • B' Neurology Department, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Univeristy Hospital, 10676 Athens, Greece.
  • Tzartos NeuroDiagnostics, 3, Eslin Street, 11523 Athens, Greece.
  • Clinical Sciences, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.

ORCID-Profile: Marios Pantzaris

Förderung

  • The Cyprus Institute of Neurology and Genetics
  • Greek EPANEK

Zitieren

APA

Pafiti, A., Krashias, G., Tzartos, J., Tzartos, S., Stergiou, C., Gaglia, E., Smoleski, I., Christodoulou, C., Pantzaris, M., & Lambrianides, A. (2023). A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310787

Vancouver

Pafiti A, Krashias G, Tzartos J, Tzartos S, Stergiou C, Gaglia E, et al. A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310787

BibTeX
@article{Pafiti2023,
  author = {Pafiti, Anna and Krashias, George and Tzartos, John and Tzartos, Socrates and Stergiou, Christos and Gaglia, Eftychia and Smoleski, Irene and Christodoulou, Christina and Pantzaris, Marios and Lambrianides, Anastasia},
  title = {A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241310787}
}
Kostenlos starten →